ArticleBone marrow transplantation2025

Validation of Manhattan risk to predict aGvHD severity in Rapamycin and PTCy-based prophylaxis: a study on 459 consecutive HCT patients.

Alessandro Criscimanna et al.PubMed ↗Publisher ↗

No numbers read from the abstract.